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Abstract  
AIM: The aim of the study was to examine whether ephedrine and phenylephrine were different in 
their efficacy for managing maternal hypotension and their effect of adverse maternal and neonatal 
outcome. 
METHODS: A double-blind randomized controlled study in healthy pregnant women ASA physical 
status 2, which underwent elective caesarian delivery under spinal anesthesia. Patients were 
randomized to receive an intravenous bolus of either phenylephrine (Ph group) or ephedrine (E 
group) immediately after the episode of hypotension after spinal anesthesia. Maternal and neonatal 
outcomes were recorded. 
RESULTS: Two hundred and two (202) pregnant women at term were entered in this study. There 
were no differences between group E and group Ph regarding the incidence of hypotension after 
vasopressor therapy, and the incidence of nausea and vomiting. There was no significant difference 
between groups in the first-minute and the 5th minute Apgar score, none of the neonates had the 
true fetal acidosis. 
CONCLUSIONS: Ephedrine and phenylephrine have the same efficacy in treating hypotension 
after spinal anesthesia for caesarean section. The use of Phenylephrine was associated with better 
fetal acid-base status, and there were no differences on Apgar score values and on the incidence of 
maternal bradycardia and hypotension.  
 
 
 
 
Introduction 
 
Hypotension associated with spinal 
anesthesia is a common complication during 
caesarean section and can result in adverse effects 
for both mother and infant [1, 2]. When maternal 
hypotension associated with spinal anesthesia for 
cesarean section is severe and sustained, it can lead 
to maternal complications (nausea, dizziness, 
faintness) as well as impairment of the uterine and 
intervillous blood flow, with consecutive fetal hypoxia, 
acidosis, and neonatal depression [3]. The 
sympathectomy resulting from the neuraxial blockade 
is exaggerated by the physiological changes of 
pregnancy and puerperium, leading to hypotension in 
as much as 55%-90% of the mothers receiving spinal 
anesthesia for Cesarean section [4]. Phenylephrine 
and ephedrine are the vasoconstrictor agents which 
are currently being recommended and used for 
controlling hypotension, but still nowadays the choice 
of vasopressor has been debated [5]. 
Phenylephrine is the α-agonist recommended 
to treat hypotension that affects approximately half of 
caesarean sections under spinal anaesthesia [6, 7]. 
Also, ephedrine was the vasoconstrictor agent of 
choice in obstetric anaesthesia for many years due to 
its favourable pharmacodynamic profile; many animal 
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models have demonstrated a marked increase in 
uteroplacentary blood flow [5, 8]. Results of several 
trials suggest that phenylephrine may have similar 
efficacy to ephedrine for preventing and treating 
hypotension during spinal anesthesia [9-12]. However, 
the relative effects of these vasopressors on neonatal 
outcome [8] and maternal outcome are unclear, and 
there is need for a large double-blind randomized 
controlled trial with emphasis on important maternal 
and neonatal outcomes [13]. 
The aim of the study was to examine whether 
ephedrine and phenylephrine were different in their 
efficacy for managing maternal hypotension after 
spinal anesthesia for Caesarean section and their 
effect of adverse maternal and neonatal outcome. 
  
 
Materials and Methods 
 
This study was approved by the Ethics 
Committee of the University of Medicine, Tirana, 
Albania. It has been performed in accordance with the 
ethical standards displayed in the 1964 Declaration of 
Helsinki and its later amendments. Written informed 
consent was obtained from all patients. Data were 
made anonymous for analysis. 
A double-blind randomized controlled study in 
healthy pregnant women ASA (American Society of 
Anesthesiologists) physical status 2, that underwent 
elective caesarian section under spinal anesthesia, 
during January 2013 - May 2015 period in University 
Hospital of Obstetrics and Gynecology "Koço 
Gliozheni" in Tirana. 
The exclusion criteria were: emergency 
cesarean section, active labor, high risk pregnancies 
(multiple gestations, intrauterine growth retardation, 
preeclampsia maternal cardiovascular or pulmonary 
diseases) and other active medical disorders requiring 
regular medication), and any contraindication of spinal 
anesthesia (patient refusal, coagulopathy, 
hemorrhage or hypovolemic shock). 
All patients fasted for at least 8 hours before 
induction of spinal anesthesia. Upon arrival to the 
operating room, all patients were monitored for basal 
vital signs (heart rate: HR, systolic and diastolic blood 
pressures: BPs, and pulse oximetry: SaO2). Baseline 
systolic arterial blood pressure was measured by 
averaging 3 readings taken 1 minute apart using an 
automated device for non-invasive blood pressure 
assessment. A 16-G IV catheter was placed in a 
peripheral vein in the patient's upper limb, and before 
performing spinal anesthesia, all patients received a 
preload of 500 ml and a coload of 1000 ml   lactated 
Ringer's solution. 
After completion of fluid infusions all patients 
received spinal anesthesia by an anesthesiologist, in 
sitting position at L3-L4 inter vertebral space, using 
26-gauge, pencil point needle. Hyperbaric 
bupivacaine 12.5 mg mixed with preservative-free 
fentanyl 10 μg and morphine 200 μg was injected over 
30 seconds. Immediately after spinal anesthesia, all 
patients were positioned in the supine position with 
left uterine displacement. Concomitantly to the 
intrathecal injection the patient received 10 mL/kg of 
lactated Ringer's solution. 
BP was controlled every minute until delivery 
and then every five minutes throughout anesthesia. 
HR and SaO2 were monitored throughout anesthesia. 
Hypotension was considered a decrease in 
systolic blood pressure > 20% of baseline (prior to 
drugs being placed in the neuraxis) [11]. Patients 
were randomized to receive an intravenous bolus of 
either phenylephrine or ephedrine immediately after 
the episode of hypotension after spinal anesthesia. 
Randomization was performed using a computer-
generated random number table. The patient and the 
attending anesthesiologist were blinded to the group 
allocation. Group allocations were placed in opaque, 
sealed envelopes on initial randomization. There were 
two groups of 101 patients: group Ph (Phenylephrine), 
and group E (Ephedrine). According to the 
randomization, hypotension  was treated: with 100 μg 
Phenylephrine bolus IV, in Ph group or 5 mg bolus 
Ephedrine, in E group. If, at any time, maternal 
systolic blood pressure was < 80% baseline, the 
rescue doses of 100 μg Phenylephrine bolus IV, in Ph 
group or 5 mg bolus Ephedrine, in E group, were 
used. The doses of phenylephrine and ephedrine 
were chosen empirically, based on our clinical 
experience of the drugs. We recorded the number of 
total doses of vasopressors given up to the time of 
uterine incision.  Heart rate and rhythm were 
monitored with ECG and any change from normal 
(tachycardia, bradycardia) were recorded and treated 
as needed. Bradycardia: HR < 60 bpm for 2 
consecutive readings 1-minute apart [10]. If a patient 
developed bradycardia, 0.6 mg atropine was 
administered. 
After delivery and clamping of umbilical cord, 
1 mL blood was drawn from the umbilical artery for 
neonatal blood gas analysis. 
The primary outcome was the incidence of 
maternal hypotension and secondary outcomes 
collected were:  intra-operative maternal compli-
cations (incidence of hypertension: SBP > 120% 
baseline, the incidence of bradycardia,  the incidence 
of  nausea: reported spontaneously by patients and 
vomiting: observed by investigators)  and neonatal 
outcome parameters (the first- and fifth-minute Apgar 
scores: assessed by the attending paediatrician, and 
the umbilical artery blood gas analysis, obtained from 
a double-clamped segment of umbilical cord upon 
delivery). True fetal acidosis was defined as an 
umbilical arterial pH value of < 7.20 [14]. 
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Statistical analysis 
Continuous variables were presented as the 
mean ± SD (standard deviation). Categorical variables 
were expressed as actual numbers (n) and 
percentages (%). Chi-square analysis was applied to 
compare frequencies between ­groups, and Student’s 
t-tests, one-way ANOVA or non-parametric tests when 
necessary were employed for quantitative variable 
analysis. Analysis was performed using the statistical 
software Statistics Package for Social Scientists 
(SPSS) version 15.0. Statistical significance was 
considered to be at the level of P ≤ 0.05. All tests 
were two-tailed. 
 
  
Results 
 
Two hundred and two (202) pregnant women 
at term were entered in this study. Details of maternal 
demographic characteristics are summarized in Table 
1.  
Table 1: Maternal Characteristics 
  Group E Group Ph P value 
Age (year) 31.5 ± 5.34 30.26 ± 4.11 0.06 
Weight (kg) 81.29 ± 12.66 79.74 ± 11.56 0.18 
Height (cm) 165.49 ± 3.02 166.02 ± 5.47 0.39 
Gestational age (weeks) 39.14 ± 0.85 39.07 ± 0.76 0.73 
Induction-to-delivery time (min) 9.54 ± 2.35 9.47 ± 1.97 0.81 
Data are given as mean ± SD. 
  
 
The two groups were similar with respect to 
maternal age, weight, height, parity, and gestational 
age. Indications for cesarean section were repeated 
cesarean in 112 (55.44%) patients, other obstetrical 
indications for cesarean (cephalopelvic disproportion, 
breech or other abnormal presentations) in 77 
(38.11%), and in 13 patients (6.43%) were patient’s 
preference. The time from induction of spinal 
anesthesia to delivery was similar in both groups 
(range from 5 to 15 minutes). Maternal hemodynamic 
variables are detailed in Table 2. 
Table 2: Comparison of systolic blood pressure (BP) and heart 
rate (HR) between two groups 
  Group E Group Ph P value 
Basal Systolic BP (mmHg) 114.75 ± 8.46 116.72 ± 7.72 0.08 
Systolic BP (mmHg) after 
anesthesia 
82.0 ± 8.95 90.05 ± 6.40 < 0.0001 
Systolic BP (mmHg) after  
vasopressor therapy 
111.79 ± 15.96 118.13 ± 10.31 0.0009 
HR at baseline (bpm) 101.78 ± 15.77 97.9 ± 17.16 0.09 
HR after anesthesia (bpm) 68.81 ± 10.29 66.68 ± 8.23 0.10 
Data are given as mean ± SD 
 
Maternal  complications 
Hypotension: 52 patients (51.48%) in group E 
and 56 patients (55.44%) in group Ph had persistent 
severe hypotension and needed additional 
vasopressor therapy. There was no significant 
difference between the groups regarding the number 
of doses of vasopressor required. (P = 0.82) (figure 1). 
In group E, 25 patients (24.75%) experienced 
bradycardia and needed one dose Atropine. 34 
patients (23.76%), in group Ph had bradycardia. 
There was no significant difference between groups 
regarding the incidence of bradycardia (P = 0.65). 
Nineteen (19) patients (16.83%) in group E 
and 12 patients (11.88%) in group Ph had nausea. 
Vomiting occurred in 4 patients (3.96%) in group E 
and in 10 patients (9.9%) in group Ph. There was no 
significant difference when comparing the incidence of 
nausea and vomiting between groups, respectively P 
= 0.87, and P = 0.47. 
 
Figure 1: Comparison of systolic blood pressure value between 
groups 
  
Neonatal complications 
First-minute Apgar scores were as follows: 6 
neonates of group E (5.94%) and 7 neonates of group 
Ph (6.93%) had Apgar score 7; 17 neonates of group 
E (16.83%) and 12 neonates (11.88%) of group Ph 
had Apgar score 8; 78 neonates of group E (77.22%) 
and 82 neonates (81.18%) of group Ph, had Apgar 
score 9. There was no significant difference between 
groups regarding the first-minute Apgar scores. 
Fifth-minutes Apgar scores were: two 
neonates in group E (1.98%) and none neonate 
(0.0%) in group Ph had mean Apgar score 8; 44 
neonates (43.56%)  in group E and 73 neonates 
(72.27%) in group Ph had mean Apgar score 9; 55 
neonates in group E (54.45%) and 28 neonates 
(27.72%) in group Ph had a mean Apgar score of 10. 
Also there was no significant difference between 
groups regarding the fifth-minute Apgar scores. 
Table 3: Neonatal Data 
  Total Group E Group Ph P value 
Umbilical arterial PH 7.32 ± 0.04 7.31 ± 0.04 7.33 ± 0.04 0.0005 
HCO3 (mmHg) 22.55 ± 2.10 22.57 ± 1.87 22.52 ± 2.32 0.86 
Base excess (mmol.l
-1
) - 3.39 ± 1.90 - 3.48 ± 2.02 - 3.30 ± 1.78 0.50 
 
Data are given as mean ± SD 
 
At 1 and 5 min, no neonate in the Ephedrine 
or Phenylephrine groups had an Apgar score value of 
< 7. 
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Umbilical arterial blood gas analyses are 
summarized in Table 3. Based on the one-way 
ANOVA test, there was a significant difference in PH 
between groups.  Umbilical arterial PH was 
significantly lower in ephedrine group (P = 0.0005), 
but none of the neonates had the true fetal acidosis 
(Figure 2). There were no differences between groups 
regarding HCO3 concentrations and base excess 
values (Be) in the umbilical arterial blood gas 
analyses. 
 
Figure 2: Comparison of umbilical arterial blood pH value between 
the study groups 
  
 
Discussion 
 
In this study, we showed no significant 
differences between ephedrine and phenylephrine in 
their efficacy for treating spinal-induced intra-operative 
hypotension during cesarean sections. Also, there 
were no differences on maternal and neonatal 
outcomes, although parturients treated with 
phenylephrine had neonates with higher umbilical pH 
value than those treated with ephedrine. These results 
were consistent with the systematic review performed 
by Lee at al [8] and the meta-analysis performed by 
Lin et al [15]. 
As in other studies, [8, 10, 12, 16, 17] we 
showed there was no difference between groups for 
the treatment of maternal hypotension with Ephedrine 
and Phenylephrine. Lin et al [15] in a recent meta-
analysis showed that when used to treat hypotension, 
patients given ephedrine and phenylephrine had 
comparable incidence of intra-operative hypotension. 
Our findings support the fact that ephedrine and 
phenylephrine are equally effective in controlling 
maternal hypotension [18]. 
In the contrary with other previous studies, [8, 
10, 11, 19] that showed that patients in the 
Phenilephrine group were more likely than the 
Ephedrine group to develop bradycardia, in the 
present study there was no difference on the 
incidence of bradycardia between two groups. 
Cooper showed that ephedrine use, 
compared with phenylephrine, was associated with a 
higher incidence of maternal nausea and vomiting 
[20]. We didn't find any difference in the incidence of 
maternal nausea and vomiting between two groups. 
The findings in the present study are in 
accordance with other studies [21, 22]: women given 
phenilephrine had neonates with higher umbilical 
arterial pH values than those given ephedrine, 
although there is no risk for true fetal acidosis in none 
of groups. 
The reason for the difference in umbilical 
arterial pH values is that ephedrine crosses the 
placenta; [17, 22, 23] therefore, it is possible that 
ephedrine may have a direct effect on the fetus that 
contributes to acidosis [8]. In spite of this, fetal clinical 
adverse effects caused by reduced fetal pH have not 
been demonstrated [24]. 
In the present study none of the neonates had 
Apgar scores < 7, so there was no difference in the 
risk of low Apgar scores at 1 min or at 5 min (< 7) 
between the Ephedrine and Phenylephrine groups [8, 
25]. 
Limitations on the study: One possible 
limitation is that the study was conducted in a single 
center. Also, it was focused only in elective cesarean 
section and in healthy non-laboring women, not 
considering other conditions affecting maternal or 
neonatal outcome. 
 In conclusion, which of the two vasopressors: 
ephedrine or phenylephrine, is superior in treating 
spinal-induced intra-operative hypotension during 
cesarean sections, has been argued for years. In 
summary, this study supports the idea that ephedrine 
and phenylephrine have the same efficacy in treating 
hypotension after spinal anesthesia for caesarean 
section. 
The use of Phenylephrine was associated 
with better fetal acid-base status compared to the use 
of ephedrine, but there were no differences on Apgar 
score values and on the incidence of the maternal 
bradycardia and hypotension after the use 
ofphenilephrine or ephedrine for treating spinal-
induced intra-operative hypotension during cesarean 
sections. 
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